News
Sexual activity rarely a heart-stopping ... Sexual activity is rarely associated with sudden cardiac arrest, ... (10 Nov 2017)
Risks for blood clot in a vein may rise with ... Risk of blood clots increases with the amount of time spent ... (10 Nov 2017)
Low sodium-DASH diet combination ... A combination of reduced sodium intake and the DASH diet lowers ... (10 Nov 2017)
Gobbling your food may harm your waistline ... People who eat slowly are less likely to become obese or develop ... (10 Nov 2017)
Drinking coffee may be associated with ... Drinking coffee may be associated with a decreased risk of ... (10 Nov 2017)

Chondroitin Outperforms Celecoxib in Knee Osteoarthritis Study

knee OAFor the first time, chondroitin sulfate has been more successful than celecoxib in reducing the long-term progression of knee osteoarthritis (OA), according to new research findings presented at the American College of Rheumatology Annual Meeting in San Francisco.
Osteoarthritis is a slowly progressive disease in which joint cartilage breaks down. Normally, cartilage on the ends of bones allows smooth, pain-free joint movements. In OA, cartilage becomes thin and irregular, resulting in symptoms of joint pain and stiffness. Grinding or cracking sensations may occur. Joints that are under high stress due to repeated activity or weight bearing are most susceptible to OA. The hips, knees, hands and spine are commonly affected. OA becomes more common with aging.
Chondroitin sulfate, more commonly called chondroitin, has long been the subject of debate when it comes to its usefulness in treating OA. Canadian researchers recently explored how this treatment would affect how OA progresses as well as how it compared to celecoxib – an often used first-line symptomatic treatment in the disease.
“We felt the present study was necessary in order to establish — using the most recent imaging technology available, quantitative magnetic resonance imaging (qMRI) — whether chondroitin sulfate can truly and effectively reduce the progression of the disease in patients suffering from knee OA,” says lead investigator in the study, Jean-Pierre Pelletier, MD; professor of medicine, University of Montreal; director, Rheumatic Disease Unit, Department of Medicine, University of Montreal School of Medicine; head, Arthritis Division, University of Montreal Hospital Centre (CHUM); head, Chair in Osteoarthritis of the University of Montreal; and director, Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM).
Dr. Pelletier’s team studied 194 people with knee OA and inflammation of the synovial membrane in the knee. The participants were followed for two years and were divided into two groups. The first group took 1200mg (pharmacological preparation) of chondroitin daily, and the second group took 200mg of celecoxib daily.
After the initial evaluation, the researchers followed up with participants again at one and two years to look at a number of factors that would indicate the effectiveness of chondroitin. At all three touchpoints with the participants, the researchers performed MRIs to detect loss of cartilage, changes in bone marrow legions, and thickening of the synovial membrane in the knee. Additionally, patients were evaluated for swelling and fluid in the knee and their overall symptoms — collected through the visual analogue scale and Western Ontario and McMaster Universities Osteoarthritis Index; VAS and WOMAC, respectively.
At both one and two years, the researchers found a better reduction of cartilage loss in the whole knee, and more particularly in the inner half, of the participants on chondroitin when compared to those on celecoxib. Additionally, there was a decrease in synovial membrane thickness in some of the participants on chondroitin, showing far better results for this group. “These findings are most important as they demonstrate that chondroitin, in contrast to celecoxib, can reduce the loss of cartilage, at least in part, by reducing synovial inflammation (thickness),” Dr. Pelletier says.
Both groups noticed a marked reduction in swelling and fluid in the knee in a large number of patients. Both groups also showed a similar effectiveness at reducing OA symptoms over the course of the study. Finally, both groups were able to reduce the amount of acetaminophen they took each day, and both experienced a good tolerance to the treatment they were taking.
“This study demonstrates that both chondroitin sulfate and celecoxib are equally effective at reducing the symptoms of knee OA patients. However, only chondroitin sulfate was found to be capable of slowing down the progression of the disease by reducing the loss of cartilage,” Dr. Pelletier remarks, while also noting further studies to establish the effect of chondroitin in other joints could be of interest.
While these results are promising, Dr. Pelletier would like to point out that the study only used pharmaceutical-grade chondroitin, and results may not be similar for all chondroitin products such as food supplements. Therefore, he recommends that patients consult with their physicians on the use of such treatment for OA.



Source Newsroom: American College of Rheumatology (ACR)
Citations
ACR Annual Meeting, Nov-2015

TheSynapse Videos

0
0
0
0
0
0

Highlights

  • Free Clinic Rooms Available

    Pharmasal, a chain of 6 retail pharmacies has a number of free clinic rooms available within the pharmacies in Tarxien, St. Paul’s Bay, Zejtun, and Dingli. We are looking to increase our list of family doctors and specialists. Family doctors are given preference for the clinic at Zejtun.  For more information, please send an email to This email address is being protected from spambots. You need JavaScript enabled to view it. or call on 99425939.

    Written on October 18, 2017
  • AVAILABLE CLINICS

    Rational Pharmacy, Valley Road, B'Kara requires consultants & family doctors for early morning & afternoon sessions.

    Please contact 99891732 or This email address is being protected from spambots. You need JavaScript enabled to view it. for more information.

    Written on October 09, 2017

Links

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Template Settings

Theme Colors

Cyan Red Green Oranges Teal

Layout

Wide Boxed Framed Rounded
Patterns for Layour: Boxed, Framed, Rounded
Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…